1. Home
  2. SRPT vs DLB Comparison

SRPT vs DLB Comparison

Compare SRPT & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
    SELLHOLDBUYas of a day ago
  • DLB
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • SRPT 1980
  • DLB 1965
  • Country
  • SRPT United States
  • DLB United States
  • Employees
  • SRPT N/A
  • DLB N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • DLB Multi-Sector Companies
  • Sector
  • SRPT Health Care
  • DLB Miscellaneous
  • Exchange
  • SRPT Nasdaq
  • DLB Nasdaq
  • Market Cap
  • SRPT 9.8B
  • DLB 7.9B
  • IPO Year
  • SRPT 1997
  • DLB 2005
  • Fundamental
  • Price
  • SRPT $70.41
  • DLB $79.96
  • Analyst Decision
  • SRPT Buy
  • DLB Strong Buy
  • Analyst Count
  • SRPT 21
  • DLB 4
  • Target Price
  • SRPT $164.05
  • DLB $99.50
  • AVG Volume (30 Days)
  • SRPT 2.2M
  • DLB 522.2K
  • Earning Date
  • SRPT 04-30-2025
  • DLB 05-01-2025
  • Dividend Yield
  • SRPT N/A
  • DLB 1.65%
  • EPS Growth
  • SRPT N/A
  • DLB 40.49
  • EPS
  • SRPT 2.34
  • DLB 2.70
  • Revenue
  • SRPT $1,901,979,000.00
  • DLB $1,315,146,000.00
  • Revenue This Year
  • SRPT $67.83
  • DLB $7.56
  • Revenue Next Year
  • SRPT $25.66
  • DLB $5.47
  • P/E Ratio
  • SRPT $30.11
  • DLB $29.60
  • Revenue Growth
  • SRPT 52.97
  • DLB 2.71
  • 52 Week Low
  • SRPT $69.82
  • DLB $66.35
  • 52 Week High
  • SRPT $173.25
  • DLB $89.66
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 27.35
  • DLB 40.65
  • Support Level
  • SRPT $70.91
  • DLB $81.14
  • Resistance Level
  • SRPT $76.67
  • DLB $82.63
  • Average True Range (ATR)
  • SRPT 4.14
  • DLB 1.40
  • MACD
  • SRPT -1.57
  • DLB -0.12
  • Stochastic Oscillator
  • SRPT 1.78
  • DLB 16.58

Stock Price Comparison Chart: SRPT vs DLB

SRPT
DLB
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025020406080100120140160180SRPT VS DLB

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About DLB Dolby Laboratories

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use